CJC 1295 with DAC 5mg

$160

CJC-1295 with DAC (C165H269N47O46) is an albumin-binding GHRH-receptor agonist supplied for laboratory research into sustained growth hormone secretion pathways. For research use only — not for human consumption.

In stock

Description

Peptides will arrive in a lyophilized (powder) form for maximum stability.

CJC-1295 with DAC is a growth hormone-releasing hormone (GHRH) analog based on the GRF(1-29) sequence, conjugated to a Drug Affinity Complex (DAC) maleimidopropionic acid linker that promotes covalent binding to circulating albumin. Molecular formula: C165H269N47O46; molecular weight: 3647.25 g/mol; CAS 446262-90-4.

Research on CJC-1295 with DAC has examined how albumin conjugation extends systemic persistence relative to unmodified GHRH analogs, and its sustained agonism at the GHRH receptor influencing pulsatile growth hormone secretion in animal and in vitro models.

Supplied as a lyophilized powder for reconstitution, each batch is analyzed by HPLC to confirm purity and identity.

For laboratory research use only. Not for human or veterinary use, and not intended for diagnostic or therapeutic application.